IMS2009国际医药市场研究报告.pdf

IMS 2009 Pharmaceutical Market Forecast: New Reality for 2009 Pharmaceutical Market Presented by Diana Conmy, Corporate Director, Market Insights October 2, 2008 IMS 2009 Pharmaceutical market forecast The World pharmaceutical market All reproduction rights, quotations, broadcasting, publications reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without express written consent of IMS HEALTH. • 2 Today’s agenda • Global market forecast for 2009 −Key numbers −Key regions • Characteristics of 2009 “new” pharmaceutical market −Dynamics and drivers of the 2009 market • Key events and wildcards −What to watch for during 2009 • Implications of 2009 “new” pharmaceutical market −What it means for pharmaceutical forecasters • 3 Forecasting challenge: The future will look vastly different from the past • New product performance is significantly less than historical performance • Pharma competitors behavior is much less predictable than it has been • Traditional forms of professional promotion are less effective than they have been • Anticipating payer actions becomes more important than physician acceptance • Patients decisions made after a prescription is written becomes more important than actual prescription itself • Economic factors have more influence on the pharmaceutical market than they have had in the past • 4 Characteristics of 2009 “New” Pharmaceutical Market New Reality New Opportunities • Mature markets experience slowing • “Pharmerging” markets grow growth strongly as healthcare environment